Articles & Treatises

< View Archived Articles & Treatises

Smart Pill: When Private Labels Need a Closer Look, IP Law & Business, June 2009
Lauren S. Albert, David H. Reichenberg


Lessons from the Great Depression, ANTITRUST, Spring 2009
John D. Harkrider


Will NJ Be The Next "Rocket Docket"?, IP Law360, March 5, 2009
Andrea Johnson Sweet


Will New Jersey Be The Next "Rocket Docket"?, Intellectual Property Today, March 2009
Andrea Johnson Sweet


Ask the Experts: Experts Discuss Effect of NJ Rules on Hatch-Waxman Litigation, Generic Line, February 4, 2009
Chad A. Landmon, Andrea Johnson Sweet


Increasing Antitrust Enforcement Under Obama?, Competition Law360, December 30, 2008
Michelle H. Seagull


Authorized Generics: Consumer Friend or Foe?, The Intellectual Property Committee Newsletter, The Section of Antitrust Law of the American Bar Association, Fall 2008, Volume Eight, Number One
Michelle H. Seagull


Ask the Expert: Michelle Seagull Comments on Cipro Antitrust Case, Generic Line, FDAnews, October 29, 2008
Michelle H. Seagull


Cipro: A Road Map For Reverse Payment Litigation, IP Law360, Health Law360, and Competition Law360, October 28, 2008
Michelle H. Seagull


Raising Questions About Patent Deception, Connecticut Law Tribune, October 13, 2008
Jeremy C. Lowe


Ask the Expert: Impact of Federal DJ Jurisdiction Decision, Generic Line, September 3, 2008
Chad A. Landmon


Federal Circuit Draws the Line on DJ Jurisdiction, IP Law360 and Health Law360, August 25, 2008
Chad A. Landmon


Antitrust Enforcement During the Bush Administration, ANTITRUST, Summer 2008
John D. Harkrider


Co-Author: The Perfect Storm for Pharmaceutical Patents: The Impact of Recent Court Decisions and Pending Litigation, 14 IP LITIGATOR 9 (2008).
Ithti T. Ulit


FDA's Exclusivity Forfeiture Saga Continues, IP Law360 and Health Law360, May 15, 2008
Chad A. Landmon


Ask the Expert: Caraco's Impact on Declaratory Judgment Actions, Generic Line, May 14, 2008
Chad A. Landmon


Ask the Expert: Impact of FDA's Exclusivity Forfeiture Rulings, Generic Line, April 30, 2008
Chad A. Landmon


Raising the Bar of Patentability, Conneticut Law Tribune, April 21, 2008
Matthew J. Becker, Thomas K. Hedemann


Here Comes The Tidal Wave of Generic DJ Actions, IP Law360 and Health Law360, April 3, 2008
Chad A. Landmon


FDA Removes Teeth From Exclusivity Forfeiture, IP Law360 and Health Law360, January 25, 2008
Chad A. Landmon


Antitrust Issues in IP Licensing, NY, NY, November 13, 2007
Michael L. Keeley


Doe v. Norwalk Community College Analysis for LexisNexis Expert Commentaries, November 2007
Richard S. Order


What is Patentable?, IP Law and Business, October 2007
Matthew J. Becker, Thomas K. Hedemann


Supreme Court Backhands Key Federal Circuit Test, IP Law360, January 10, 2007
Chad A. Landmon


An Overview of FDA Regulation: What the Canadian Biomedical Industry Needs to Know, November 8, 2006
John Will Ongman


Club Dues, The Deal, October 10, 2006
Michael L. Keeley


Fourth Circuit Rejects Another Authorized Generics Challenge, IP Law360 and Health Law360, July 19, 2006
Chad A. Landmon


Antitrust's New Big Brother: Feds Can Now Wiretap Suspected Offenders, American Bar Association, Section of Business Law, July 2006
Mark D. Alexander


On Demand: Focusing The Patent Scope, The Connecticut Law Tribune, Intellectual Property Supplement, May 8, 2006; also published in The Connecticut Tech Tribune, July 2006
Chad A. Landmon


FDA's "Holding On The Merits" Test, IP Law360, April 21, 2006
Chad A. Landmon


Arbitration Freed From American Fee Rule, The Connecticut Law Tribune, Business Litigation Supplement, April 17, 2006
Richard S. Order


Recent Court Rulings Indicate That Patent Rights May Trump the Antitrust Laws, Intellectual Property Today, April 2006
Chad A. Landmon


Second Circuit Puts Antitrust Conspiracy's Skeletal Pleading Rules on a Diet, The Antitrust Source, March 2006
Mark D. Alexander


Freedom from Filing: The FTC Should Reconsider Investor Activism under the Hart-Scott-Rodino Act, The Deal, February 6, 2006
Michael L. Keeley


Exporting Antitrust Law to China, Global Competition Review, February 2006
John D. Harkrider


Operationalizing the Hypothetical Monopolist Test
John D. Harkrider


Risk-Shifting Provisions and Antitrust Risk: An Empirical Examination, ANTITRUST, a publication of ABA Section of Anitrust Law, Fall 2005
John D. Harkrider


The "Narrowed Claim Conundrum" Resulting from Reissue and Reexamination Proceedings, Intellectual Property Today, Vol. 12, No. 10, October 2005
Chad A. Landmon


Rethinking Second Requests, The Deal, September 26, 2005
Lauren S. Albert


The Impact of a Brand Generic Launch on the Recovery of Patent Damages, IPL Newsletter, Vol. 23, No. 4, Summer 2005
Chad A. Landmon, James D. Veltrop


"Schering" Overruled: Risk of Settling Patent Suits Reduced?, N.Y.L.J., April 7, 2005
Michael L. Keeley, James D. Veltrop


Hell's Angles, The Deal, February 14, 2005
William M. Rubenstein


Sophistication Snag, The Deal, January 17, 2005
John D. Harkrider


Proving Anticompetitive Impact: Moving Past Merger Guidelines Presumptions, 2004 Milton Handler Antitrust Review, 2005 Colum. Bus. L. Rev. 317, 2005
John D. Harkrider


Class Action Reaction: Ameded Rule 23 Enhances Judicial Supervision in Class Litigation, ANTITRUST, a publication of ABA Section of Antitrust Law, Spring 2004
Michelle H. Seagull

< View Archived Articles & Treatises